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Objectives: To evaluate the early experience with transfemoral endovascular ortic aneurysm management using the 
Endovascular Grafting System. TM 
Design: Multi-centre prospective evaluation of the implantation procedure and early results (median follow-up 153 
days). 
Setting: Department of Surgery, University Hospital Utrecht, The Netherlands; Department of Surgery, University of 
Sydney, Australia; University of Leicester School of Medicine, Leicester, U.K., Department of Surgery, Karolinska 
Hospital, Stockholm, Sweden and Nuffield Department ofSurgery, University of Oxford, John Radcliffe Hospital; Oxford, 
U.K. 
Materials: 31 consecutive patients treated in 13 months. 
Chief outcome measurements: Peri and postoperative morbidity and mortality in accordance with the recommendations 
of the Ad Hoc Committee on Reporting Standards. 
Main results: Graft placement was initially successful inall 31 patients. In one patient he endografl had to be replaced 
by a standard aortic tube graft because of extra grafl flow in the aneurysm sac, and complaints of back pain. One patient 
died from multiple organ failure, 11 days after the operation. In three patients five severe adverse vents were recorded. 
Breaks of the attachment system were encountered in two patients. These failures did not have severe clinical consequences 
for individual patients. 
Conclusions: Transfemoral Endovascular Aneurysm Management is a technically demanding procedure that requires 
special training in both catheter and surgical techniques. The potential for less operative morbidity when compared to 
conventional surgery and the prospect of technical improvements in graft and introduction system design will make TEAM 
an important tool in aneurysm anagement i  the near future. 
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Introduction 
Total population based mortality from ruptured 
abdominal aortic aneurysm is about 85%. Even for 
patients who reach hospital alive, the mortality is 
around 50%. ~-6 Prophylactic replacement of the dis- 
eased section of aorta by either a tube or a bifurcated 
graft is therefore considered in patients with enlarging 
aneurysms and aneurysms > 5 cm diameter. 7-9 In 
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surgery of non-ruptured abdominal aneurysms, eri- 
ous-complication rates as high as 5-10% and overall 
operative mortality rates of 7% are reported. 1°
In the hope of reducing the operative morbidity and 
mortality a minimally invasive, transfemoral method 
of treating aortic aneurysms has been developed. 11-17 
In this technique, access to the vascular system is 
gained by dissection of the femoral artery. Through a 
catheter the prosthesis i positioned inside the aorta, 
excluding the aneurysm sac from the vessel umen. 
The first results obtained in England, Sweden, Aus- 
tralia and the Netherlands, ofa clinical study with the 
EndoVascular Grafting System (EGS) TM are reported. 
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Materials and Methods 
Approval for a phase 1 study of the EGS TM was given 
by the Food and Drug Administration (FDA). The 
study protocol is identical in all participating centres 
and is approved by local ethical committees. The 
endovascular prosthesis includes a standard Dacron 
vascular graft with metal attachment systems affixed 
to both ends of the graft. The attachment systems 
comprises a self-expanding cylindrical metal frame 
with a series of angled metal attachment hooks. 
Criteria for patient selection 
The endovascular grafting system has been designed 
for treatment of asymptomatic infrarenal aortic aneu- 
rysms. All selected patients had an aneurysm that, by 
current standards, required surgical repair. Informed 
consent was obtained. To ensure proper selection of 
candidates, high quality preoperative imaging is 
needed. 18-2° Selection is based on length and diameter 
measurements from CT and an arterial angiography 
with a calibrated catheter. All patients were selected 
for suitability for endovascular tubegraft implanta- 
tion. Since the anchoring of the graft depends on the 
proximal and distal attachment systems, the candi- 
dates must have a non-dilated aortic segment (neck) 
between the renal arteries and the aneurysm and 
between the aneurysm and the aortic bifurcation. The 
minimum required length of the proximal neck is 15 
mm and of the distal neck 10 mm. On at least one side, 
the iliac and femoral artery must have a diameter of 
more than 7.7 mm to allow passage of the EGS. The 
diameter of available prostheses varies from 18 to 28 
mm in 2 mm increments, the length from 9 to 13 cm in 
0.5 cm increments. Very tortuous iliac arteries are a 
contraindication to Endograft placement but mild 
elongation of the iliac artery can be overcome by 
mobilizing and stretching the iliac artery. 
Implantation technique 
The EGS TM and Endograft® (EndoVascular Technolo- 
gies, Menlo Park U.S.A.) are implanted in the operat- 
ing room using general anesthesia nd endotracheal 
intubation. This allows for conversion to a standard 
operating technique if necessary during the proce- 
dure. To monitor the placement of the endoprosthesis 
a mobile image intensifier and a radiolucent operating 
table are needed. The patient is positioned supine over 
a "marker board" containing two moveable radio- 
paque marker lines. The marker lines are positioned at 
the level at which the proximal and distal attachment 
systems are to be deployed, cephalad just below the 
origin of the lowest renal artery and caudad at the 
level of the aortic bifurcation. At the start of the 
procedure 5000 IU of heparin and prophylactic antibi- 
otics are administered intravenously. Access to the 
vascular system is obtained through a common 
femoral artery cutdown. A guide wire and a calibrated 
angiography catheter are then inserted and positioned 
in the aorta. Angiography is performed using a 
mechanical injector. From the calibration markers on 
the angiography catheter the final length of the 
prosthesis can be determined. 
Through a femoral arteriotomy, a specially designed 
sheath is introduced over the guide wire and posi- 
tioned with its distal end in the aorta, just cephalad to 
the aortic bifurcation. The sheath contains two dia- 
phragm valves to minimise blood loss during the 
insertion of the EGS. The sheath facilitates insertion of 
the device and protects the iliac and femoral artery 
during the EGS procedure. The EGS is a coaxial 
catheter containing the Endograft with its proximal 
and distal attachment systems and a balloon used for 
driving the hooks on the proximal and distal attach- 
ment stents into the aortic wall. The EGS is inserted 
while constantly monitoring its position by fluoros- 
copy. The proximal attachment system is deployed 
level with the proximal marker line. When the 
Endograft opens proximally it fills with blood. To 
reduce the risk of distal migration of the graft the 
mean arterial blood pressure is lowered to 60 mmHg. 
The deflated balloon, lying inside the graft, is 
advanced to the level of the attachment system and 
inflated to a pressure of 2 atmospheres for i min. This 
step is repeated after deflation and minor reposition- 
ing of the balloon. During the second inflation an 
arteriogram is performed percutaneously through the 
contralateral femoral artery to permit repositioning of 
the distal marker line if necessary. After correction of 
any twist in the Endograft, guided by radiopaque 
markers on the Dacron graft, the distal attachment 
system is delivered and fixed by balloon inflation. The 
delivery system is withdrawn into the sheath in the 
iliac artery and completion angiography performed. 
Special attention is paid to any flow outside the graft 
into the aneurysm sac. The delivery system and sheath 
are removed and the arteriotomy closed. 
Follow-up 
The day after the procedure abdominal radiography 
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and Duplex-u l t rasonography are performed. Before 
discharge from hospital, a computer ised tomography  
is done. Dup lex-u l t rasonography and abdomina l  
rad iography are repeated at 6 weeks, 6 months  and  
every 12 months  after implantat ion.  CT is repeated at 
6 months  and every year after implantat ion.  
Selected patients 
From September 1993 through September 1994, 31 
consecutive patients, 27 males and four females, were 
treated with the EGS. No implants  were inserted in 
pat ients by  the part ic ipant surgeons before the s tudy 
and no patients were left out of the study. The med ian  
age of pat ients was 71 years (range 51-86 years). 
Twenty-one out of 31 Patients were current smok- 
ers, 12 had a history of hypertension,  10 suffered from 
per ipheral  vascular disease, seven had diabetes mell i-  
tus, six had symptomat ic  coronary artery disease, four 
had a history of cardiac arrhythmia and three had 
suffered a previous stroke. One pat ient  had a cardiac 
transplant.  The max imum aneurysm diameter  meas- 
ured on CT images ranged from 36 mm in a saccular 
aneurysm to 75 mm in a fusiform aneurysm.  The 
med ian  aneurysm diameter  was 51 mm. Median  
fol low-up was 153 days (range 2432 days). 
Results 
In all 31 patients the Endograft  was successful ly 
implanted.  In two pat ient calcifications in the femoral  
and external iliac artery prevented int roduct ion of the 
EGS. A temporary  extra per i toneal  i iac condui t  us ing  
a Dacron tube, anastomosed to the common iliac 
artery was successful ly used in these two patients. The 
med ian  durat ion  of all operations, from incision to 
closure, was 125 rain (range 60-305 rain). 
Table 1. Adverse events 
Adverse vents 
Number of patients 
A B C 
mild moderate severe 
Systemic remote 
Cardiac arrhythmia 1 
Respiratory failure due to brochopneumonia 1
Stroke 0 
Renal insufficiency 1 
Sepsis 1 
Multiple organ failure 0 
Pyrexia of unknown origin 1 
Local vascular 
Graft/vessel interaction, extra graft flow 6 
Damage to access artery 0 
Damage to contralateral femoral artery 0 
Atherothromboembolism 2 
Bloodtransfusion requirement 0 
Local nonvascular 
Wound infection, superficial 1 
Wound fluid accumulations, haematoma 2 
Wound fluid accumulations, lymphocele 0 








A = no haemodynamic consequence; B = required treatment; 
C = cardiac arest/fatal 
A = transient, not requiring ventilator; B = transient, required 
ventilator; C = permanent/death 
A = TIA; B = permanent deficit; C = fatal 
A = transient, not requiring dialysis; B= transient, requiring 
dialysis; C = permanent/fatal 
A = requiring drug therapy; B= requiring resuscitation; 
C = fatal 
A = requiring drug therapy; B= requiring resuscitation; 
C = fatal 
A = resolved without reatment; B = required rug therapy; 
C -- required operation/fatal 
A = observed, no therapy; B= required intervention, stenting; 
C = required redo operation/conversion 
A = observed, no treatment, B = required local treatment; 
C = required extensive vascular repair 
A = observed, no treatment; B = required local treatment; 
C = required extensive vascular repair 
A = without issue loss; B = minor tissue loss/amputation; 
C = major tissue loss/amputation 
A = no blood administered; B = blood transfusion required; 
C = fatal 
A = treated with antibiotic; B = treated with drainage; C = graft 
removal or bypass 
A = observed, resolved; B= aspirated; C = surgical drainage 
A = observed, resolved; B= aspirated; C = surgical drainage 
A = observed, no therapy; B= required local treatment; 
C = required redo operation/conversion 
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Mortality 
The 30 day postoperative mortality was 3.2% (one 
patient). The patient who died 11 days after operation 
had a history of myocardial infarction and stroke. His 
implantation procedure was without technical prob- 
lems and took 120 min but insufficient peripheral 
circulation in the contralateral lower limb, due to 
catheter damage to the femoral artery, made local 
exploration of the femoral artery in the groin and 
fasciotomy necessary, several hours after the Endog- 
raft implantation. He continued to deteriorate and 
developed renal respiratory and cardiac failure lead- 
ing to his death. 
One patient died after 180 days because of a 
pancreatic arcinoma, one other after 222 days from 
the sequelae of an esophageal rupture, not related to 
either the graft implantation or the vascular disease 
and one patient died from stroke 330 days after the 
operation. 
Adverse vents 
Early adverse vents occurred in the first 30 days after 
the operation and following the recommendations of 
the Ad Hoc Committee on Reporting Standards, 21
were graded as mild(A), moderate(B) or severe(C). 
Forty-one early adverse events were observed in 23 
patients (Table 1). There were no late complications in
the 29 surviving patients in the follow-up group. 
Several of the adverse events need some explana- 
tion. Three of the five severe, grade C, adverse vents; 
namely: renal insufficiency; multiple organ failure and 
damage to the contralateral femoral arter~ occurred in 
the patient who died 11 days after operation. Of the 
two patients with a temporary (grade B) respiratory 
insufficiency, one had also suffered a stroke, and.the 
other developed temporary renal insufficiency but did 
not require haemodialysis. The one patient with sepsis 
was taking immunosuppressive therapy for a cardiac 
transplant. 
Pyrexia of unknown origin was observed in four 
patients. Three of these were treated with antibiotics. 
In all four cases the pyrexia disappeared, and no other 
signs of infection were observed. Intimal damage to 
the access artery requiring local repair occurred in 
four patients. In the two mild, grade A, cases of 
atherothromboembolism the patients had a "trash 
foot", their skin lesions healed without amputation or 
tissue loss. In the one patient with moderate athero- 
thromboembolism a toe amputation was performed 
after several weeks. 
All blood transfusion requirements arose from 
blood loss through the femoral arteriotomy. There 
were no cases of retroperitoneal or intra-abdominal 
blood loss. 
Extra graft flow 
In seven patients postoperative Duplex ultrasonog- 
raphy and CT showed initial extra-graft flow, i.e. 
blood entering the aneurysm sac. In four cases the 
extra graft flow entered at the proximal attachment 
system and in three cases at the distal attachment 
system. 
Of the four patients with proximal extra graft flow, 
one subsequently had standard operative tube graft 
insertion. In two of the remaining three cases the extra 
graft flow ceased spontaneously on the 5th day and 3 
weeks respectively after implantation. In the remain- 
ing case the extra graft flow was still present at 9 
months follow-up. Of the three cases with extra graft 
flow originating at the distal attachment system one 
spontaneously resolved after 2 weeks and of the other 
two the extra graft flow was still present after 6 weeks 
in one and after 6 months in the other case. 
Attachment system breaks 
In two patients an unexpected fracture of one of the 
attachment systems of the endovascular graft was 
encountered. These failures occurred between 6 and 
12 months follow-up. The fractures did not have 
clinical consequences other than intensified follow-up, 
and there were no signs of graft failure, graft disloca- 
tion or extra graft flow in these two patients. 
Conversion 
In one patient the Endograft was removed on the 
second postoperative day. The initial operation in this 
patient was without problems. The angiogram on 
completion of the TEAM procedure did not show 
contrast leakage outside the Endograft. The CT- 
angiogram and Duplex-ultrasonography examina- 
tions the day following the procedure showed extra 
graft flow, in the aneurysm sac, at the level of the 
proximal attachment system. The reason for this extra- 
graft flow was non-alignment of the proximal attach- 
ment system because the prosthesis was too short. The 
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maximum length of available prosthesis was 12 cm at 
that time and, in retrospect, a 13 cm prosthesis was 
needed. On the second postoperative day he com- 
plained of back pain and it was decided to replace the 
Endograft with a conventional tube graft. During the 
laparotomy it was observed that there were no 
macroscopic changes in the retroperitoneum and the 
aorta was not damaged. The Endograft was removed 
and a tube graft inserted without technical problems. 
Recovery was uneventful and the patient was dis- 
charged from hospital 10 days after the second 
operation. 
Hospital stay 
In the 29 successful cases, excluding the case that was 
converted on the second day and the patient who 
died, the median postoperative hospital stay was 7 
days (range 2-40 days). 
Discussion 
Five to eight percent of men older than 65 years have 
an abdominal aneurysm. 2~-2s Standard surgical treat- 
ment of an infrarenal aneurysm requires a major 
abdominal operation to replace the aneurysm with a 
prosthesis. The relatively high rate of serious compli- 
cations and operative mortality 6 has stimulated the 
search for a safer and simpler treatment. 
The first reports of endovascular graft placement 
date back to the late sixties 26. After the publication of 
experiments in animals, 27-29 Volodos et al. published 
their results with a self fixing synthetic prosthesis and 
Parodi et al., in 1991, reported clinical cases of 
transfemoral endoluminal treatment of abdominal 
aneurysms with a Dacron graft sutured to Palmaz 
stents. 11"B° These and other results showed that both 
tube and bifurcated grafts could successfully be 
introduced through the femoral artery. 13'15 
The applicability of the EGS is limited by the 
requirement for a segment of normal aorta between 
renal artery origins and the aneurysm and between 
the aneurysm and the aortic bifurcation. A majority of 
patients with an asymptomatic aneurysm will there- 
fore not be suitable for the operationY '32 Recently a 
bifurcated endograft device, based on the same princi- 
ples as the tube graft, has been approved by the Food 
and Drug Administration in the United States for a 
limited phase I clinical trial. The bifurcated evice is 
anchored in both common iliac arteries and can be 
used in patient with no normal aorta below the 
aneurysm. It is expected that the bifurcated evice will 
permit the TEAM procedure to be offered to many 
more patients. 
There was a high total number of complications in 
the 31 patients reported. Because of the design of the 
study it is not possible to compare morbidity with the 
current standard operation. Such comparisons can 
only be made in a randomised prospective study of 
the two operations. Of major concern is the occurrence 
of atherothromboembolic complications. The micro- 
thrombi were probably released uring the introduc- 
tion of the guide wire and the EGS into the aneurysm. 
The risk of emboli originating from the iliac artery on 
the side of introduction is minimized by the use of the 
expandable sheath. 
Of the seven cases with extra graft flow three 
showed spontaneous closure of the leak in the 6 weeks 
after the operation. In one patient he Endograft had to 
be removed two days after the initial operation and 
was replaced by a standard tube graft. So far only two 
of the remaining extra graft flow cases have a follow- 
up of more than 6 months. In these two cases the 
aneurysm has not shown any increase in diameter. 
The long term consequences of leaks at the site of the 
attachment systems are unknown and can only be 
determined by long term follow-up of all patients. If 
during follow up of these patients the aneurysm size 
nevertheless increases open surgery should be per- 
formed. During the follow-up, no cases with persis- 
tent retrograde flow from lumbar arteries or the 
inferior mesenteric artery were seen. 
The problem of extra graft flow has also been 
addressed by Moore and Vescera 31. In this series of ten 
patients, with eight successful procedures, they 
encountered four patients with extra graft flow. Two of 
these spontaneously resolved. The other two showed 
no enlargement of the aneurysm - -  one after 6 months 
and one after 1 year of follow-up. 
It is noteworthy that in our series of 31 patients we 
did not encounter graft infection, graft migration, 
graft occlusion, secondary aneurysm formation or 
aortoenteric fistula. 
This series shows that the TEAM procedure for 
aortic aneurysm is feasible. Before the operation is 
generally introduced it is necessary to study a larger 
number of patients with extended follow-up. Long 
term surveillance will demonstrate he ultimate fate of 
the proximal and distal attachment systems. Gradual 
dilatation of the aorta at the level of the attachment 
systems may cause leakage and stent migration. The 
role of patent lumbar and mesenteric arteries on the 
pressure in the thrombosed aneurysm sac is also 
unknown. 
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Recently breaks in the attachment system of the 
endograft 6 months to 1 year after graft implantation 
have been discovered. The probable cause of these 
failures is metal fatigue due to excessive stress on the 
attachment systems. In this series of 31 patients this 
problem was encountered in two patients. There have 
been no adverse clinical consequences. It has however 
been decided to temporarily suspend patient enrol- 
ment in the clinical trials and await results of the 
investigation by the manufacturer. Follow-up on all 
patients is intensified, all patients will be examined 
every 3 months. It is expected that the trials will 
continue after modification of the attachment 
systems. 
The TEAM procedure requires training in both 
catheter and surgical techniques. The principal inves- 
tigators in all centres were trained in an animal 
laboratory and performed several procedures on 
calves before they started treating patients. All proce- 
dures were coached by a team from EndoVascular 
Technologies. The cumulative xperience ofthe coach- 
ing team was invaluable and undoubtedly contributed 
greatly to the success of the operations. We recom- 
mend a combined input from both vascular surgeons 
and an interventional radiologist. 
Our first experiences show that the TEAM proce- 
dure, although feasible in patients, is not without its 
problems. The technique is likely to improve in the 
next few years and we expect hat it will come to play 
a major role in future aneurysm anagement. 
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